Harrow, Inc. (HROW) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
14/25
Growth 4
Margin 3
Expansion 5
Platform 0
Financial 2
latest quarter score
Earnings Reports
- 14
- 14
- 21
- 21
- 25
- 22